Literature DB >> 8702934

Cleavage arrest of early frog embryos by the G protein-activated protein kinase PAK I.

R D Rooney1, P T Tuazon, W E Meek, E J Carroll, J J Hagen, E L Gump, C A Monnig, T Lugo, J A Traugh.   

Abstract

PAK I is a member of the PAK (p21-activated protein kinase) family and is activated by Cdc42 (Jakobi, R., Chen, C.-J., Tuazon, P. T., and Traugh, J. A. (1996) J. Biol. Chem. 271, 6206-6211). To examine the effects of PAK I on cleavage arrest, subfemtomole amounts of endogenously active (58 kDa) and inactive (60 kDa) PAK I and a tryptic peptide (37 kDa) containing the active catalytic domain were injected into one blastomere of 2-cell frog embryos. Active PAK I resulted in cleavage arrest in the injected blastomere at mitotic metaphase, whereas the uninjected blastomere progressed through mid- to late cleavage. Injection of other protein kinases at similar concentrations had no effect on cleavage. Endogenous PAK I was highly active in frog oocytes, and antibody to PAK I reacted specifically with protein of 58-60 kDa. PAK I protein was decreased at 60 min post-fertilization, with little or no PAK I protein or activity detectable at 80 min post-fertilization or in 2-cell embryos. At the 4-cell stage PAK I protein increased, but the protein kinase was present primarily as an inactive form. Rac2 and Cdc42, but not Rac 1, were identified in oocytes and throughout early embryo development. Thus, PAK I appears to be a potent cytostatic protein kinase involved in maintaining cells in a non-dividing state. PAK I activity is high in oocytes and appears to be regulated by degradation/synthesis and through autophosphorylation via binding of Cdc42. PAK I may act through regulation of the stress-activated protein kinase signaling pathway and/or by direct regulation of multiple metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702934     DOI: 10.1074/jbc.271.35.21498

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2.

Authors:  Jun Ling; Simon J Morley; Jolinda A Traugh
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

2.  XPak3 promotes cell cycle withdrawal during primary neurogenesis in Xenopus laevis.

Authors:  Jacob Souopgui; Marion Sölter; Tomas Pieler
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

3.  Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK.

Authors:  J Roig; P T Tuazon; P A Zipfel; A M Pendergast; J A Traugh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 4.  Cdc42: An essential Rho-type GTPase controlling eukaryotic cell polarity.

Authors:  D I Johnson
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

5.  Activation of Syk protein tyrosine kinase in response to osmotic stress requires interaction with p21-activated protein kinase Pak2/gamma-PAK.

Authors:  S M Shahjahan Miah; Kiyonao Sada; Polygena T Tuazon; Jun Ling; Koichiro Maeno; Shinkou Kyo; Xiujuan Qu; Yumi Tohyama; Jolinda A Traugh; Hirohei Yamamura
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

6.  Negative control of the Myc protein by the stress-responsive kinase Pak2.

Authors:  Zhongdong Huang; Jolinda A Traugh; J Michael Bishop
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Elevated p21-activated kinase 2 activity results in anchorage-independent growth and resistance to anticancer drug-induced cell death.

Authors:  Jerry W Marlin; Andrew Eaton; Gerald T Montano; Yu-Wen E Chang; Rolf Jakobi
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

8.  Photodynamic treatment induces an apoptotic pathway involving calcium, nitric oxide, p53, p21-activated kinase 2, and c-Jun N-terminal kinase and inactivates survival signal in human umbilical vein endothelial cells.

Authors:  Wen-Hsiung Chan
Journal:  Int J Mol Sci       Date:  2011-02-07       Impact factor: 5.923

Review 9.  Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signaling.

Authors:  Yunbo Ke; Ming Lei; Xin Wang; R John Solaro
Journal:  Front Pharmacol       Date:  2013-09-27       Impact factor: 5.810

10.  Novel DNA microarray system for analysis of nascent mRNAs.

Authors:  Masaya Ohtsu; Mika Kawate; Masashi Fukuoka; Wataru Gunji; Fumio Hanaoka; Takahiko Utsugi; Fumitoshi Onoda; Yasufumi Murakami
Journal:  DNA Res       Date:  2008-07-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.